PDS Biotechnology Corporation (PDSB) Stock Forecast
Data as of Sep 19, 2026Healthcare · Current price $0.85 (+0.58%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
PDSB vs Sector & Market
| Metric | PDSB | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 4 | 8 | 18 |
| Target Upside | +962.5% | +22242.6% | +21.5% |
| P/E Ratio | -1.45 | 3.76 | 38.34 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $11M | $11M | $11M | 1 |
| 2027-12-31 | $23M | $23M | $23M | 1 |
| 2028-12-31 | $4M | $4M | $4M | 1 |
| 2029-12-31 | $107M | $107M | $107M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.67 | $-0.67 | $-0.67 | 2 |
| 2027-12-31 | $-0.69 | $-0.69 | $-0.69 | 2 |
| 2028-12-31 | $-0.86 | $-0.67 | $-0.48 | 2 |
| 2029-12-31 | $0.45 | $0.45 | $0.45 | 1 |
Frequently Asked Questions
What is the analyst consensus for PDSB?
The consensus among 4 analysts covering PDS Biotechnology Corporation (PDSB) is Buy with an average price target of $9.00.
What is the highest price target for PDSB?
The highest analyst price target for PDSB is $9.00.
What is the lowest price target for PDSB?
The lowest analyst price target for PDSB is $9.00.
How many analysts cover PDSB?
4 analysts have issued ratings for PDS Biotechnology Corporation in the past 12 months.
Is PDSB a buy or sell right now?
Based on 4 analyst ratings, PDSB has a consensus rating of Buy (2.00/5) with a +962.5% upside to the consensus target of $9.00.
What are the earnings estimates for PDSB?
Analysts estimate PDSB will report EPS of $-0.67 for the period ending 2026-12-31, with revenue estimated at $11M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.